Grape King Bio Ltd.TWSE: 1707

Announcement of the Company's Consolidated Financial Report for the second quarter of 2022 has been approved by the Board of Directors

· Issued by Grape King Bio Ltd.
Close
Today's Information

Provided by: GRAPE KING BIO LTD
SEQ_NO 1 Date of announcement 2022/08/10 Time of announcement 16:24:36
Subject
 Announcement of the Company's Consolidated
Financial Report for the second quarter of 2022 has been
approved by the Board of Directors
Date of events 2022/08/10 To which item it meets paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
 directors:2022/08/10
2.Date of approval by the audit committee:2022/08/10
3.Start and end dates of financial reports or annual self-assessed financial
 information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
 2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):4,775,053
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):3,919,655
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):1,090,238
7.Profit (loss) before tax accumulated from 1/1 to end of the period
 (thousand NTD):1,149,356
8.Profit (loss) accumulated from 1/1 to end of the period
 (thousand NTD):930,807
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):620,718
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):4.19
11.Total assets end of the period (thousand NTD):14,545,490
12.Total liabilities end of the period
(thousand NTD):4,646,283
13.Equity attributable to owners of parent end of the
period (thousand NTD):8,730,774
14.Any other matters that need to be specified:None

Company analysis

Earlier from Grape King Bio

All Grape King Bio news releases